salicylamide has been researched along with ER-Negative PR-Negative HER2-Negative Breast Cancer in 1 studies
salamide: a major impurity of hydrochlorothiazide; structure in first source
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Xu, J | 2 |
| Kim, H | 1 |
| Dong, J | 1 |
| Chen, H | 1 |
| Ma, R | 1 |
| Zhou, M | 1 |
| Wang, T | 1 |
| Shen, Q | 1 |
| Zhou, J | 1 |
1 other study available for salicylamide and ER-Negative PR-Negative HER2-Negative Breast Cancer
| Article | Year |
|---|---|
Structure-activity relationship studies on O-alkylamino-tethered salicylamide derivatives with various amino acid linkers as potent anticancer agents.
Topics: Amino Acids; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; | 2022 |